Premium
Radiotherapeutic management of cancer of the supraglottis
Author(s) -
Spaulding Cynthia A.,
Krochak Ronald J.,
Hahn Seung Shin,
Constable William C.
Publication year - 1986
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19860401)57:7<1292::aid-cncr2820570707>3.0.co;2-z
Subject(s) - medicine , radiation therapy , surgery , stage (stratigraphy) , cancer , lesion , complication , survival rate , paleontology , biology
One hundred eighty‐five patients with cancer of the supraglottis were treated with curative intent by radiotherapy alone or combined with surgery over a 14‐year period. Minimum follow‐up was 3 years. Sixty‐eight percent had Stage III or IV disease. Moderate‐dose radiotherapywith surgery in reservewas the policy for the early lesionsand yielded a 3‐year locoregional control rate of 76% for T1 N0/N1T2 N0/N1and T3 N0/N1 lesions combined. In this group84% of patients with locoregional control retained laryngeal function. The major complication rate was 4%. Patients with advanced disease were treated with preoperative radiotherapy and surgeryresulting in an overall 3‐year no evidence of disease rate of 72%. Adverse prognostic factors in supraglottic cancer were the extent of the primary lesion and the presence of N2 or N3 nodes. Neither vocal cord fixation nor N1 nodes had a negative influence on survival in T3 and T4 disease.